Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest chemotherapy Stories

2013-12-20 08:25:46

SYDNEY, Dec. 20, 2013 /PRNewswire/ -- Novogen Limited, an oncology drug development company, announced today the signing of a Sponsored Research Agreement with Cornell University. The Weill Cornell Medical College (WCMC) in New York will become the cornerstone of a collaboration across Europe, US, Asia and Australia involving universities and biotechnology companies seeking a treatment capable of delivering long-term remission for the main form of primary brain cancer, glioblastoma...

2013-12-19 04:20:55

LUGANO, Switzerland, December 19, 2013 /PRNewswire/ -- The two companies sign a distribution and license agreement for an investigational therapy for the prevention of chemotherapy-induced nausea and vomiting covering China, Hong Kong and Macao Helsinn and Mundipharma announce the signature of a new, exclusive license and distribution agreement, covering China, Hong Kong and Macao, for netupitant-palonosetron fixed dose combination (NEPA), a Helsinn product under...

2013-12-18 12:26:28

Community Oncology Alliance gravely concerned over severe cuts to cancer care WASHINGTON, Dec. 18, 2013 /PRNewswire/ -- The Community Oncology Alliance (COA) issued a plea today to Congress to immediately stop the latest round of payment cuts the Obama Administration will make effective January 2014 to providing chemotherapy and other life-saving drugs to seniors with cancer. Additionally, COA called on Congress to stop the sequester cut to cancer drugs by passing the Cancer Patient...

2013-12-18 11:12:18

Men with Hodgkin lymphoma who want to become fathers after their cancer treatment have greatly increased chances of doing so if they have frozen and stored semen samples beforehand, according to research published online today (Wednesday) in Europe's leading reproductive medicine journal Human Reproduction. In the first study to investigate the impact on fatherhood of freezing semen prior to cancer treatment, researchers questioned 902 male survivors of Hodgkin lymphoma in five European...

2013-12-16 18:14:37

Rates of programmed cell death higher in mice treated with experimental drug than in untreated animals with same cancer An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer, scientists will report on Tuesday Dec. 17, at the American Society for Cell Biology (ASCB) annual meeting in New Orleans. The...

2013-12-16 12:25:23

CINCINNATI, Dec. 16, 2013 /PRNewswire-USNewswire/ -- Using genetic information initially uncovered in fruit fly studies, scientists have developed a unique therapeutic strategy that stops an aggressive and deadly form of leukemia in laboratory models of the disease. (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Reporting their results Dec. 16 in the Journal of Clinical Investigation, researchers say their findings provide strong evidence for developing clinical...

2013-12-16 08:25:29

- Initial results for BL-8040 show substantial mobilization of cancer cells and signs of robust cancer cell death (apoptosis) - JERUSALEM, Dec. 16, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute...

2013-12-14 23:03:17

In response to an article published by Yotta Fire, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a study that looks into a new and effective method of delivering chemotherapy drugs directly to brain cancer patients. New York, NY (PRWEB) December 14, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by Yotta Fire on December 4th that discusses a new...

2013-12-14 23:01:48

Scientists in Italy say vinorelbine may be a promising option for patients whose cancer returns after chemotherapy. Raleigh, NC (PRWEB) December 14, 2013 The anti-mitotic drug vinorelbine may be a safe and effective treatment for mesothelioma patients whose cancer progresses after first-line chemotherapy with the standard drugs. Pemetrexed (Alimta) is the primary first-line chemotherapy drug for mesothelioma patients with unresectable disease. The drug is usually paired with a...

2013-12-14 08:20:06

Fourth Head-to-Head Comparison Reveals Important Clinical Distinctions Between Oncotype DX, the Only Test Demonstrated to Predict Chemotherapy Benefit, and Tests Limited to Breast Cancer Prognosis REDWOOD CITY, Calif., Dec. 14, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from three studies of its Oncotype DX(®) breast cancer test presented at the 36(th) Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), reinforcing the unmatched value of the...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »